Clinical trial
DialysisBot: Design, Implementation, and Evaluation of an AI-based Conversational Agent to Support Self-management in Patients Undergoing Hemodialysis
NCT07830810 is registered in ClinicalTrials.gov with University of Rome Tor Vergata as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- DialysisBot: Design, Implementation, and Evaluation of an AI-based Conversational Agent to Support Self-management in Patients Undergoing Hemodialysis
- Lead sponsor
- University of Rome Tor Vergata
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- October 1, 2026
- Completion date
- November 15, 2026
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chatbot-based training, hemodialysis, self-management